Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals

Table 3 Flavivirus-specific antibodies in colostrum and serum of JE + ADVAX™ vaccinated and unvaccinated mares at the time of foaling ^a

	Colostrum			Serum
Mare #	JEV neutralizing antibody titres	MVEV neutralizing antibody titres	WNV_KUNneutralizing antibody titres	JEV neutralizing antibody titres	MVEV neutralizing antibody titres	WNV_KUNneutralizing antibody titres
2	2560	80	< 40	40	< 20	< 20
5	160	< 40	< 40	20	20	< 20
8	640	80	< 40	20	< 20	< 20
10	640	80	80	40	20	80
11	320	40	< 40	< 20	20	< 20
14	640	80	< 40	20	< 20	< 20
17	320	40	< 40	40	40	40
21	160	40	< 40	< 20	< 20	< 20
26	160	80	< 40	20	< 20	< 20
33	640	80	40	40	40	80
34	640	< 40	< 40	40	< 20	< 20
Control A^b	160	40	< 40	< 20	< 20	< 20
Control B	40	40	< 40	< 20	< 20	< 20
Control C	320	40	< 40	< 20	< 20	< 20

^aSamples negative in the flavivirus (4G2) blocking ELISA were not tested in the neutralization assays. This included three control mares (D-F), which are not shown in the Table.
^bEntered trial at time of foaling, having received neither JEV + Advax nor Advax alone.

ISSN: 1297-9716